IRAK4 and inflammatory bowel disease: Owing to its role in TLR signaling, IRAK4 is involved in the release of several inflammatory cytokines and chemokines; therefore, hyperactivity of IRAK4 signaling can ultimately lead to several inflammatory disorders such as rheumatoid arthritis and inflammatory bowel disease [7].